Industry committee  Every possible candidate was explored, and AstraZeneca was one of them. Our current option is to get it through COVAX. Perhaps Mark or Roger could speak further to the AstraZeneca option.

Industry committee  I could start on that, Madam Chair. As we looked at the candidates from a vaccine point of view, there are some vaccine platforms that have been used in programs since the 1950s when we started to roll out public health programs, so we would have a lot more experience and knowle

Industry committee  We had a process in place whereby potential interests were categorized under nine categories, then the impacts of those potential interests were considered by the secretariat. We were overly disclosing any potential interest. Normally you would disclose something involving an i

Industry committee  Yes, there were. There were, I think, 29 or 30 instances in which people recused themselves.

Industry committee  Good morning. Thank you so much, Madam Chair, and thank you to the committee for inviting us today. I'm really honoured to be with you today as the co-chair of Canada's vaccine task force. I think I speak for my colleague, Mark Lievonen, who is here, and all task force members